News – Page 587 – Endpoints News

Under the gun with Aduhelm floundering, Biogen sells its stake in biosimilars business for $2.3B

4 years ago

Amgen, Regeneron and others seek more detail from FDA on real-world data plans

4 years ago

FDA offers new guidance to help generic drug developers get to market more quickly

4 years ago

Reigning cystic fibrosis champ Vertex wows analysts, again — but can a heavyweight contender deliver a blow?

4 years ago

Biotech gets burned at a fireside chat as CEO reveals FDA clamped a hold on its cancer drug, now under review

4 years ago

Scott Gottlieb criticizes CMS in feud over Aduhelm coverage, calls out their lack of expertise

4 years ago

With the CDC under fire for mixed messages again, can new communication strategies help recoup public trust?

4 years ago

Fujifilm expands in US after $100M deal for Atara's manufacturing site and employees

4 years ago

Law professors join fight against J&J's controversial move to spin out talc assets and file for bankruptcy

4 years ago

Can new manufacturing approaches finally make a decades-old cell therapy idea a reality?

4 years ago

To expand its oral and topical dosage options, Catalent will put $10M into micronization

4 years ago

Covid-19 manufacturing roundup: Brazil to manufacture Vaxzevria at home; AstraZeneca ramp up in Spain gets the OK

4 years ago

OneTouch diabetes brand updates its playbook with ex-NFL spokesperson and digital lifestyle one-stop shop

4 years ago

Keytruda for HIV? Researchers claim it's a possibility — opening more doors toward cure

4 years ago

Covid-19 roundup: Moderna kicks off trial for Omicron-specific vaccine; EMA signs off on Pfizer pill

4 years ago

Ziopharm rebrands to Alaunos, closes Boston office with new CEO at the reins

4 years ago

With Forty Seven co-founder at the helm, new biotech spinout launches to target mutations potentially linked to ...

4 years ago

Going after an old GSK target in a new way, a Yale spinout hits the clinic and nabs a modest raise

4 years ago

Selling shares at a discount, Zymeworks grabs $100M cash in hopes of turnaround

4 years ago

Under pressure, Biogen outlines ambitious diversity goals for Aduhelm study — but the Medicare fight is still on

4 years ago

Pfizer wants to help the FDA with its new, court-mandated $4-5M FOIA release on the company's Covid-19 vaccine data

4 years ago

A new Third Rock startup seeks a 'second golden age' of GPCR drug discovery based on Nobel laureate's work

4 years ago

Big Pharma R&D legend Paul Stoffels is trading his J&J title for the CEO role at one of the most deeply troubled ...

4 years ago

After a banner year, Samsung will charge forward with 'super plant' plans, and look to expand abroad

4 years ago

First page Previous page 584 585 586587588 589 590 Next page Last page